Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Generalized Anxiety Disorder Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

6 recruiting trials for Generalized Anxiety Disorder. Eligibility criteria explained in plain English.

TrialFinderData lists 6 Generalized Anxiety Disorder clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by University Hospital, Bordeaux (1), University of Minnesota (1), Jasper A. Smits (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Anxiety-induced task (behavioral, 1 trial), followed by Neuropsychiatric assessment, Negative Emotions and Addiction Tools Program (NEAT)- Cognitive Behavioral Therapy.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
6
Sponsors

Track Generalized Anxiety Disorder trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05393518

Electroclinical Correlation of Anxiety

Anxiety disorders have the highest prevalence among mental disorders and cause considerable individual and financial costs. Current treatments do not relieve mental suffering of...

Sponsor: University Hospital, BordeauxEnrolling: 301 location
RECRUITINGNCT05117255

Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy...

This project is designed to determine if a computer-delivered cognitive-behavioral treatment can improve the otherwise poor alcohol use disorder treatment outcomes for individuals...

Sponsor: University of MinnesotaEnrolling: 2561 location
RECRUITINGNCT05467683

CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy

Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a...

Sponsor: Jasper A. SmitsEnrolling: 6002 locations
RECRUITINGNCT04900064

Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial

In this multicenter study, the investigators want to find out if an addition of an diagnostic assessment and possibility of treatment with guided self-help CBT can increase the...

Sponsor: Linnaeus UniversityEnrolling: 12424 locations
RECRUITINGNCT06934525

Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings

The purpose of this study is to test how the delivery of Cognitive Behavioral Therapy (CBT) for pediatric anxiety and OCD via different methods might increase its availability and...

Sponsor: Bradley HospitalEnrolling: 5011 location
RECRUITINGNCT06537128

Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

Anxiety is very common in autistic youth. Cognitive behavioral therapy (CBT) is the recommended treatment for both autistic and typically-developing (TD) youth with anxiety, yet...

Sponsor: Baylor College of MedicineEnrolling: 1391 location

Frequently Asked Questions

There are currently 6 clinical trials for Generalized Anxiety Disorder, with 6 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Generalized Anxiety Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Generalized Anxiety Disorder, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.